Screening for endometrial cancer

Area of Science:

• Gynecologic Oncology
• Preventive Medicine
• Oncology

Background:

• Population screening for cervical neoplasia is common, but endometrial neoplasia screening is emerging.
• Endometrial carcinoma development parallels premalignant changes seen in cervical neoplasia.
• Screening for endometrial cancer is supported by a defined high-risk population and accessible diagnostic methods.

Purpose of the Study:

• To evaluate the potential for screening for endometrial neoplasia.
• To identify high-risk groups amenable to endometrial cancer screening.
• To assess the feasibility of current tissue sampling techniques for endometrial screening.

Main Methods:

• Identification of women at increased risk for endometrial carcinoma.
• Utilizing endometrial aspiration devices for tissue sampling.
• Performing screening in an office setting, similar to intrauterine device insertion.

Main Results:

• High-risk groups include obese postmenopausal women, those on hormone replacement therapy, premenopausal women with anovulatory cycles, and women with hepatic cirrhosis.
• Endometrial aspiration devices allow for accurate, easy, inexpensive, and well-tolerated tissue sampling.
• Screening can be performed by physicians experienced with intrauterine contraceptive device insertion.

Conclusions:

• Screening for endometrial hyperplasia and carcinoma is a viable option for high-risk women.
• The clinical impact of routine endometrial cancer screening requires further investigation through large-scale studies.
• Early detection through screening may improve outcomes for endometrial cancer.